U.S. FDA issues Warning Letter for the Company's Somerset, New Jersey (USA) facility

Lupin Ltd has received a warning letter from the U.S. FDA for the Company's Somerset, New Jersey facility. The U.S. FDA had inspected the Lupin Somerset site from September 10, 2020 to November 5, 2020.

The Company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility.

The company is committed to addressing the concerns raised by the U.S. FDA and will work with the FDA and the New Jersey District to resolve these issues at the earliest. The company upholds quality and compliance issues with utmost importance and are committed to be compliant with Good Manufacturing Practice standards across all its facilities.

Shares of LUPIN LTD. was last trading in BSE at Rs.1230.25 as compared to the previous close of Rs. 1229.6. The total number of shares traded during the day was 119531 in over 3659 trades.

The stock hit an intraday high of Rs. 1240.35 and intraday low of 1222. The net turnover during the day was Rs. 147595189.

Source : Equity Bulls

Keywords